WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3'4301 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 5'0541 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 190  189  187  186  185  175  163  156 
Births
Surviving infants
Pop. less than 5 years 25  26  26  26  26  26  23  24 
Pop. less than 15 years 72  72  72  71  71  71  66  72 
Female 15-49 years 43  43  42  42  42  39  38  34 

Number of reported case

(Click for retrospective incidence data for Samoa)
Diphtheria
Japanese encephalitis
Measles 376 
Mumps
Pertussis 22  113 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Samoa)
Vaccine year result method % card seen                                                
BCG 2007  84  DHS   40  95  96  100  91  94  97  97  72 
DTP1 2007  77  DHS   40  100  99  100  97  91  94 
DTP3 2007  38  DHS   40  95  92  91  87  72  100  90  29 
HepB_BD          91  96  100  91  75  99 
HepB3          95  99  91  87  72  96 
Hib3          95  99  91  87  72 
JapEnc         
MCV 2007  63  DHS   40  99  85  67  61  49  93  89 
MCV2          87  67  65  45  29 
PCV1         
PCV3         
Pol3 2007  34  DHS   40  95  95  91  86  72  100  88  29 
Rota1         
Rota_last         
Rubella1          99  85  67  61  49 
TT2plus          22  100  70 
PAB         
VAD1          79 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Samoa)
BCG 95  96  99  91  94  97  97  72 
DTP1 99  99  99  97  91  99  96  54 
DTP3 95  92  91  87  72  99  90  29 
HepB3 95  99  91  87  72  96 
HepB_BD 91  96  99  91  75  99 
Hib3 95  99  91  87  72 
MCV 99  85  67  61  49  93  89 
MCV2 87  67  65  45  29 
PCV3
Pol3 95  95  91  86  72  99  88  29 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 33
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 5 years; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
HepB birth; Yes
MMR 12, 15 months; Yes
OPV 6, 10, 14 weeks; Yes
Td 1st contact pregnancy;+1, +6 months; +1, +2 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  No  No  No  Yes  Yes 
What years does the MYP cover? number 2013 - 2015          2008-2010  2007-2008 
Nº of districts with microplans that include activities to raise immunization coverage number       10  11 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 43  11 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100    56  67 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 56      22   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes  Yes  No  No  Yes   

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.